Table 1 Patient demographics, sorted by clinical response
Characteristics of 5 patients with optimal seizure reduction (no detected seizures) | ||||||
sex | age | Epilepsy type(s) | Seizure type(s) | Etiology/syndrome | AEDs | Diet ratio |
M | 4.5 | generalized | Myoclonic, generalized T/C | Doose syndrome | VPA, CZP | 4:1 |
F | 4.8 | generalized | Myoclonic, tonic, absence | L-G syndrome | CLB | 3:1 |
M | 5.1 | generalized | Myoclonic, tonic | Down’s syndrome | VPA, LTG | 4:1 |
F | 5.8 | generalized | Myoclonic, generalized T/C | Cortical dysplasia (polymicrogyria) | none | 3:1 |
F | 9.0 | focal | Focal without impaired awareness | Cortical dysplasia | PRI, VPA | 4:1 |
Mean: | 5.8 | |||||
Characteristics of 5 patients with no observed change in seizures | ||||||
M | 4.0 | generalized | Myoclonic, tonic, epileptic spasms | Inverted duplicated chromosome 15, L-G syndrome | LTG, TPM | 4:1 |
M | 6.0 | generalized | Epileptic spasms, generalized T/C | L-G syndrome | VPA, LTG | 3:1 |
M | 6.3 | generalized | Myoclonic, absence, generalized T/C | Infantile spasms, L-G syndrome | VPA, CLB | 4:1 |
F | 6.7 | generalized | Generalized T/C | Unknown | LTG, PB, TPM | 4:1 |
M | 10.1 | generalized | Myoclonic, atonic | Agenesi corpus callosum, other CNS malformations | VPA, CZP | 4:1 |
Mean: | 6.6 | |||||